COL3A1 and metabolic dysfunction-associated steatohepatitis: In human NASH, expression of Col3a1 has been suggested as a biomarker for discrimination between fibrotic and non-fibrotic liver, and has been shown to be positively correlated with liver inflammation activity [68].